Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1976 Jan 1;143(1):100–113. doi: 10.1084/jem.143.1.100

Inhibition of lymphocyte trapping by a passenger virus in murine ascitic tumors: characterization of lactic dehydrogenase virus (LDV) as the inhibitory component and analysis of the mechanism of inhibition

PMCID: PMC2190100  PMID: 1244415

Abstract

Cell-free fluid from several ascites promoting tumors inhibits lymphocyte trapping. Lactic dehydrogenase virus (LDV), a common passenger virus in many mouse tumors, was found to be a trapping inhibitor component in these fluids. Procedures used to eliminate infective LDV, such as dilution, passage of the tumor through irradiated rats, ether fractionation, and ultraviolet (UV) irradiation abolished the trapping inhibitory capacity of the fluids. LDV, dissociated from tumors, was inhibitory. Lymph nodes in mice with acute, but not chronic, LDV infections were inhibited from trapping. LDV does not appear to inhibit the capacity of circulating cells to be trapped, and as measured by mitogen responsiveness, the virus does not directly interfere with T-cell function. LDV may inhibit trapping by indirectly affecting the T cell or directly affecting the macrophage in which it replicates. The known characteristics of LDV infection may explain a number of reported immunosuppressive attributes of tumor- associated ascitic fluids.

Full Text

The Full Text of this article is available as a PDF (837.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Bowman B. M. Studies on the properties of factors elevating the activity of mouse-plasma lactate dehydrogenase. Biochem J. 1964 Mar;90(3):477–482. doi: 10.1042/bj0900477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collins M. J., Jr, Parker J. C. Murine virus contaminants of leukemia viruses and transplantable tumors. J Natl Cancer Inst. 1972 Oct;49(4):1139–1143. [PubMed] [Google Scholar]
  3. Frost P. Further evidence for the role of macrophages in the initiation of lymphocyte trapping. Immunology. 1974 Oct;27(4):609–616. [PMC free article] [PubMed] [Google Scholar]
  4. Frost P., Lance E. M. Abrogation of lymphocyte trapping by ascitic tumours. Nature. 1973 Nov 9;246(5428):101–103. doi: 10.1038/246101a0. [DOI] [PubMed] [Google Scholar]
  5. Grohsman J., Nowotny A. The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid. J Immunol. 1972 Nov;109(5):1090–1095. [PubMed] [Google Scholar]
  6. Howard R. J., Notkins A. L., Mergenhagen S. E. Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus. Nature. 1969 Mar 1;221(5183):873–874. doi: 10.1038/221873a0. [DOI] [PubMed] [Google Scholar]
  7. Hrsak I., Marotti T. Mode of immunosuppressive action of Ehrlich ascitic fluid. J Natl Cancer Inst. 1974 Oct;53(4):1113–1119. doi: 10.1093/jnci/53.4.1113. [DOI] [PubMed] [Google Scholar]
  8. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  9. Kamo I., Patel C., Kateley J., Friedman H. Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts. J Immunol. 1975 Jun;114(6):1749–1756. [PubMed] [Google Scholar]
  10. Michaelides M. C., Schlesinger S. Effect of acute or chronic infection with lactic dehydrogenase virus (LDV) on the susceptibility of mice to plasmacytoma MOPC-315. J Immunol. 1974 Apr;112(4):1560–1564. [PubMed] [Google Scholar]
  11. Mongini P. K., Rosenberg L. T. Inhibition of lymphocyte trapping by cell-free ascitic fluids cultivated in syngeneic mice. J Immunol. 1975 Feb;114(2 Pt 1):650–654. [PubMed] [Google Scholar]
  12. NOTKINS A. L. LACTIC DEHYDROGENASE VIRUS. Bacteriol Rev. 1965 Jun;29:143–160. doi: 10.1128/br.29.2.143-160.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. NOTKINS A. L. RECOVERY OF AN INFECTIOUS RIBONUCLEIC ACID FROM THE LACTIC DEHYDROGENASE AGENT BY TREATMENT WITH ETHER. Virology. 1964 Apr;22:563–567. doi: 10.1016/0042-6822(64)90077-7. [DOI] [PubMed] [Google Scholar]
  14. NOTKINS A. L., SCHEELE C. IMPAIRED CLEARANCE OF ENZYMES IN MICE INFECTED WITH THE LACTIC DEHYDROGENASE AGENT. J Natl Cancer Inst. 1964 Oct;33:741–749. [PubMed] [Google Scholar]
  15. Notkins A. L., Mage M., Ashe W. K., Mahar S. Neutralization of sensitized lactic dehydrogenase virus by anti-gammglobulin. J Immunol. 1968 Feb;100(2):314–320. [PubMed] [Google Scholar]
  16. Riley V. Persistence and other characteristics of the lactate dehydrogenase-elevating virus (LDH-virus). Prog Med Virol. 1974;18(0):198–213. [PubMed] [Google Scholar]
  17. Smith J. B., Morris B. The response of the popliteal lymph node of the sheep to swine influenza virus. Aust J Exp Biol Med Sci. 1970 Feb;48(1):33–46. doi: 10.1038/icb.1970.4. [DOI] [PubMed] [Google Scholar]
  18. Snodgrass M. J., Lowrey D. S., Hanna M. G., Jr Changes induced by lactic dehydrogenase virus in thymus and thymus-dependent areas of lymphatic tissue. J Immunol. 1972 Apr;108(4):877–892. [PubMed] [Google Scholar]
  19. Turner W., Ebert P. S., Spahn G., Bassin R., Chirigos M. A. Potentiation of murine sarcoma virus (Harvey) (Moloney) oncogenicity in lactic dehydrogenase-elevating virus-infected mice. Proc Soc Exp Biol Med. 1971 Apr;136(4):1314–1318. doi: 10.3181/00379727-136-35482. [DOI] [PubMed] [Google Scholar]
  20. YAFFE D. The distribution and in vitro propagation of an agent causing high plasma lactic dehydrogenase activity. Cancer Res. 1962 Jun;22:573–580. [PubMed] [Google Scholar]
  21. Zatz M. M., Gershon R. K. Thymus dependence of lymphocyte trapping. J Immunol. 1974 Jan;112(1):101–106. [PubMed] [Google Scholar]
  22. Zatz M. M., Lance E. M. The distribution of 51Cr-labeled lymphocytes into antigen-stimulated mice. Lymphocyte trapping. J Exp Med. 1971 Jul 1;134(1):224–241. doi: 10.1084/jem.134.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES